Annual Shareholders Equity
$11.87 M
-$22.89 M-65.85%
31 December 2023
Summary:
Context Therapeutics annual stockholders equity is currently $11.87 million, with the most recent change of -$22.89 million (-65.85%) on 31 December 2023. During the last 3 years, it has risen by +$28.79 million (+170.16%). CNTX annual shareholders equity is now -75.41% below its all-time high of $48.27 million, reached on 31 December 2021.CNTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$83.86 M
-$17.25 M-17.06%
01 September 2024
Summary:
Context Therapeutics quarterly stockholders equity is currently $83.86 million, with the most recent change of -$17.25 million (-17.06%) on 01 September 2024. Over the past year, it has increased by +$65.47 million (+356.12%). CNTX quarterly shareholders equity is now -17.06% below its all-time high of $101.10 million, reached on 30 June 2024.CNTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.8% | +356.1% |
| 3 y3 years | +170.2% | +461.2% |
| 5 y5 years | - | - |
CNTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.4% | +170.2% | -17.1% | +461.2% |
| 5 y | 5 years | -75.4% | +149.5% | -17.1% | +461.2% |
| alltime | all time | -75.4% | +149.5% | -17.1% | +461.2% |
Context Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $83.86 M(-17.1%) |
| June 2024 | - | $101.10 M(+1097.5%) |
| Mar 2024 | - | $8.44 M(-28.9%) |
| Dec 2023 | $11.87 M(-65.8%) | $11.87 M(-35.4%) |
| Sept 2023 | - | $18.38 M(-23.4%) |
| June 2023 | - | $24.00 M(-16.5%) |
| Mar 2023 | - | $28.73 M(-17.3%) |
| Dec 2022 | $34.76 M | $34.76 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $38.07 M(-8.6%) |
| June 2022 | - | $41.65 M(-8.3%) |
| Mar 2022 | - | $45.39 M(-6.0%) |
| Dec 2021 | $48.27 M(-385.3%) | $48.27 M(-307.9%) |
| Sept 2021 | - | -$23.21 M(+4.1%) |
| June 2021 | - | -$22.30 M(+27.6%) |
| Mar 2021 | - | -$17.48 M(+3.3%) |
| Dec 2020 | -$16.92 M(-29.4%) | -$16.92 M |
| Dec 2019 | -$23.96 M | - |
FAQ
- What is Context Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Context Therapeutics?
- What is Context Therapeutics annual shareholders equity year-on-year change?
- What is Context Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Context Therapeutics?
- What is Context Therapeutics quarterly shareholders equity year-on-year change?
What is Context Therapeutics annual stockholders equity?
The current annual shareholders equity of CNTX is $11.87 M
What is the all time high annual shareholders equity for Context Therapeutics?
Context Therapeutics all-time high annual stockholders equity is $48.27 M
What is Context Therapeutics annual shareholders equity year-on-year change?
Over the past year, CNTX annual stockholders equity has changed by -$22.89 M (-65.85%)
What is Context Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CNTX is $83.86 M
What is the all time high quarterly shareholders equity for Context Therapeutics?
Context Therapeutics all-time high quarterly stockholders equity is $101.10 M
What is Context Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CNTX quarterly stockholders equity has changed by +$65.47 M (+356.12%)